MedX Health Corp
MDX.V
TSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -42.37% | 102.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -42.37% | 102.26% | |||
| Cost of Revenue | -46.16% | 98.31% | |||
| Gross Profit | -36.52% | 109.20% | |||
| SG&A Expenses | 306.01% | -33.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 147.01% | -12.61% | |||
| Operating Income | -254.88% | 33.97% | |||
| Income Before Tax | -40.85% | -55.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -40.85% | -55.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -40.85% | -55.27% | |||
| EBIT | -254.88% | 33.97% | |||
| EBITDA | -255.72% | 32.54% | |||
| EPS Basic | -41.38% | -52.63% | |||
| Normalized Basic EPS | -44.44% | -50.00% | |||
| EPS Diluted | -41.38% | -52.63% | |||
| Normalized Diluted EPS | -44.44% | -50.00% | |||
| Average Basic Shares Outstanding | 1.08% | -0.21% | |||
| Average Diluted Shares Outstanding | 1.08% | -0.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||